EUVIMEDEUVIMED entdecken
Crossref

Skin cancer incidence in Mexican renal transplant recipients: a cohort over 56 years

Andrea Malagón-Liceaga iD, Samantha Paola Bermúdez-Rodríguez iD, Jesús Alejandro Romero-Aguila iD, Lopez-Jimenez Fanny Carolina iD, Rebeca Palafox-Romo iD, Verónica Monserrat Díaz-Sánchez iD, Lluvia Marino-Vazquez iD, Luis Eduardo Morales-Buenrostro iD, Josefina Alberú Gómez iD, Judith Domínguez-Cherit iD, Ana Lilia Ruelas-Villavicencio iD

International Journal of Dermatology · 2024

DOI: 10.1111/ijd.17332 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Dermatology, 2024. Verfasst von Andrea Malagón-Liceaga und 10 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Department, National Institute of Nutrition Salvador Zubirán, Mexico City, Mexico. Hauptthemen laut MEDLINE: Skin Neoplasms, Kidney Transplantation, Basal Cell Carcinoma, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Skin cancer is a primary health concern in renal transplant recipients (RTRs). Existing research mainly stems from North America, Europe, and Australia, with limited data from Latin America.

Methods

This 56‐year (1967–2023) retrospective cohort study explores skin cancer incidence in Mexican RTRs. Our objective was to assess the long‐term incidence of malignant cutaneous neoplasms in Mexican RTRs.

Results

Over 56 years, 1642 RTRs (58% male) were studied. Median follow‐up was 8.4 years; median age at transplantation was 32.6 years. Skin cancer incidence was 6.6% (95% CI: 5.5–7.9), with an incidence density rate of 6.5 (95% CI: 5.4–7.9) per 1000 person‐years and a median latency of 9.8 years. Incidence increased with longer transplantation‐related immunosuppression (TRI), with a relative risk for >30 years of TRI of 4.8 (95% CI: 2.6–9.1) for any skin cancer and 7.5 (95% CI: 3.8–14.6) for squamous cell carcinoma (SCC). SCC was the most common malignancy (76.1%), followed by basal cell carcinomas (BCC), with a 3.6:1 ratio. Metastatic SCC occurred in 6.5% of skin cancer patients, with a skin cancer‐related mortality rate of 2.7%. Limitations of the study include its single‐center and retrospective design and unassessed factors such as human papillomavirus infection and sun exposure.

Conclusions

Our study provides unique insights into the epidemiology of skin cancer among Mexican RTRs. It constitutes the largest cohort of skin cancer cases among RTRs in Mexico and, to our knowledge, in Latin America. Despite the lack of recognition of a high skin cancer incidence in non‐White RTRs, our 6.6% incidence underscores the need to enhance surveillance programs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Skin NeoplasmsKidney TransplantationBasal Cell CarcinomaCarcinoma, Squamous CellHumansIncidenceMaleFemaleRetrospective StudiesMexicoMiddle AgedAdultYoung AdultMelanomaAgedTransplant RecipientsFollow-Up StudiesAdolescentImmunosuppressive Agents

Stichwörter der Autor:innen

BCCLatin AmericaSCCbasal cell carcinomaimmunocompromised patientimmunosuppression therapykidney transplantationorgan transplantationskin neoplasmssquamous cell carcinomatransplant recipients

Substanzen

Immunosuppressive Agents

Autor:innen und Institutionen

  • Dermatology Department, National Institute of Nutrition Salvador Zubirán, Mexico City, Mexico.
  • Internal Medicine Department, National Institute of Nutrition Salvador Zubirán, Mexico City, Mexico.
  • Nephrology and Renal Transplantation Department, National Institute of Nutrition Salvador Zubirán, Mexico City, Mexico.
  • Global Health and Emerging Diseases, School of Medicine and Health Sciences, Tecnológico de Monterrey, Mexico City, Mexico.

ORCID-Profile: Andrea Malagón-Liceaga, Samantha Paola Bermúdez-Rodríguez, Jesús Alejandro Romero-Aguila, Lopez-Jimenez Fanny Carolina, Rebeca Palafox-Romo, Verónica Monserrat Díaz-Sánchez, Lluvia Marino-Vazquez, Luis Eduardo Morales-Buenrostro, Josefina Alberú Gómez, Judith Domínguez-Cherit, Ana Lilia Ruelas-Villavicencio

Zitieren

APA

Malagón-Liceaga, A., Bermúdez-Rodríguez, S. P., Romero-Aguila, J. A., Carolina, L. F., Palafox-Romo, R., Díaz-Sánchez, V. M., Marino-Vazquez, L., Morales-Buenrostro, L. E., Alberú Gómez, J., Domínguez-Cherit, J., & Ruelas-Villavicencio, A. L. (2024). Skin cancer incidence in Mexican renal transplant recipients: a cohort over 56 years. International Journal of Dermatology. https://doi.org/10.1111/ijd.17332

Vancouver

Malagón-Liceaga A, Bermúdez-Rodríguez SP, Romero-Aguila JA, Carolina LF, Palafox-Romo R, Díaz-Sánchez VM, et al. Skin cancer incidence in Mexican renal transplant recipients: a cohort over 56 years. International Journal of Dermatology. 2024. doi:10.1111/ijd.17332

BibTeX
@article{MalagnLiceaga2024,
  author = {Malagón-Liceaga, Andrea and Bermúdez-Rodríguez, Samantha Paola and Romero-Aguila, Jesús Alejandro and Carolina, Lopez-Jimenez Fanny and Palafox-Romo, Rebeca and Díaz-Sánchez, Verónica Monserrat and Marino-Vazquez, Lluvia and Morales-Buenrostro, Luis Eduardo and Alberú Gómez, Josefina and Domínguez-Cherit, Judith and Ruelas-Villavicencio, Ana Lilia},
  title = {Skin cancer incidence in Mexican renal transplant recipients: a cohort over 56 years},
  journal = {International Journal of Dermatology},
  year = {2024},
  doi = {10.1111/ijd.17332}
}
Kostenlos starten →